GlassScriptPhysician profile
Caroline A D' Souza
NPI 1164541066
$6,474.59
in general payments reported to CMS, 2019-2025
50 companies · $771 in 2025
The $771 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $474 · 2021: $1,230 · 2022: $1,172 · 2023: $1,022 · 2024: $1,084 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,837 · Education: $40.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,836.66 |
| Education | $40.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $1,064.27 | 2021-2025 | |
| Abbvie INC. | $813.80 | 2019-2024 | Lo Loestrin Fe |
| Amgen INC. | $436.33 | 2019-2024 | Evenity, Prolia |
| Astellas Pharma US INC | $390.68 | 2022-2025 | Veozah, Myrbetriq |
| Myovant Sciences INC. | $367.18 | 2021-2022 | |
| Pfizer INC. | $258.56 | 2020-2024 | |
| Exact Sciences Corporation | $250.03 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Agile Therapeutics, INC. | $223.68 | 2021-2022 | |
| Exeltis, USA INC. | $197.25 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $194.41 | 2020-2022 | |
| Millicent US INC | $156.22 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Novo Nordisk INC | $149.66 | 2021 | |
| Merck Sharp & Dohme LLC | $135.58 | 2019-2022 | |
| Daiichi Sankyo INC. | $135.37 | 2021-2022 | |
| Gilead Sciences, INC. | $124.99 | 2023 | Epclusa |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline D' Souza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.